Cytosorbents CEO Phillip Chan's 2021 pay jumps 29% to $1.8M
Cytosorbents reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
Cytosorbents reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, four executives at Cytosorbents received on average a compensation package of $1.4M, a 31% increase compared to previous year.
Average pay of disclosed executives at Cytosorbents
Phillip P. Chan, Chief Executive Officer, received $1.8M in total, which increased by 29% compared to 2020. 36% of Chan's compensation, or $647K, was in stock awards. Chan also received $173K in bonus, $476K in option awards, $483K in salary, as well as $12K in other compensation.
Vincent J. Capponi, Chief Operating Officer, received a compensation package of $1.5M, which increased by 26% compared to previous year. 38% of the compensation package, or $559K, was in stock awards.
Kathleen P. Bloch, Chief Financial Officer, earned $1.2M in 2021, a 29% increase compared to previous year.
Efthymios N. Deliargyris, Chief Medical Officer, received $1.2M in 2021, which increases by 44% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 22, 2022.